X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4283) 4283
Publication (805) 805
Book Chapter (127) 127
Book Review (50) 50
Dissertation (48) 48
Conference Proceeding (26) 26
Government Document (6) 6
Book / eBook (3) 3
Data Set (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2511) 2511
humans (2408) 2408
hdac inhibitors (1623) 1623
animals (1382) 1382
histone deacetylase inhibitors (1292) 1292
hdac (1242) 1242
cancer (1147) 1147
histone deacetylase inhibitors - pharmacology (1113) 1113
oncology (1010) 1010
acetylation (951) 951
hdac inhibitor (911) 911
histone deacetylases - metabolism (911) 911
histone deacetylase (886) 886
apoptosis (874) 874
biochemistry & molecular biology (845) 845
cell line, tumor (804) 804
mice (672) 672
expression (654) 654
hydroxamic acids - pharmacology (634) 634
cell biology (608) 608
epigenetics (593) 593
pharmacology & pharmacy (543) 543
chemistry, medicinal (536) 536
gene expression (528) 528
article (512) 512
histone deacetylase inhibitor (508) 508
valproic acid (494) 494
antineoplastic agents - pharmacology (492) 492
female (491) 491
gene-expression (489) 489
apoptosis - drug effects (479) 479
male (469) 469
suberoylanilide hydroxamic acid (452) 452
proteins (435) 435
histones - metabolism (428) 428
cell proliferation - drug effects (421) 421
chromatin (409) 409
histone deacetylase inhibitors - therapeutic use (379) 379
analysis (375) 375
dna methylation (352) 352
research (347) 347
enzyme inhibitors - pharmacology (343) 343
inhibitors (323) 323
histones (322) 322
histone deacetylase inhibitors - chemistry (310) 310
transcription (301) 301
activation (296) 296
vorinostat (293) 293
cells (285) 285
histone deacetylases (283) 283
in-vivo (281) 281
histone deacetylases - genetics (279) 279
neurosciences (269) 269
differentiation (267) 267
in-vitro (265) 265
care and treatment (262) 262
health aspects (260) 260
structure-activity relationship (255) 255
dose-response relationship, drug (251) 251
enzymes (242) 242
rats (239) 239
antineoplastic agents - therapeutic use (236) 236
therapy (236) 236
cell cycle (234) 234
chemistry, organic (233) 233
neoplasms - drug therapy (230) 230
epigenetic inheritance (224) 224
methylation (221) 221
epigenesis, genetic (213) 213
genetic aspects (213) 213
histone acetylation (210) 210
growth (209) 209
antineoplastic agents - chemistry (198) 198
tumors (198) 198
cells, cultured (195) 195
hdacs (195) 195
saha (193) 193
acetylation - drug effects (192) 192
trichostatin-a (192) 192
biology (191) 191
valproic acid - pharmacology (189) 189
genetics & heredity (188) 188
chemotherapy (187) 187
blotting, western (185) 185
nf-kappa-b (185) 185
drug design (184) 184
phosphorylation (182) 182
cell line (180) 180
genes (180) 180
review (180) 180
histone deacetylases - chemistry (176) 176
phase-i (174) 174
cell survival - drug effects (173) 173
down-regulation (173) 173
drug synergism (173) 173
hematology (167) 167
gene expression regulation, neoplastic - drug effects (165) 165
histone deacetylase inhibitors - chemical synthesis (165) 165
breast cancer (161) 161
inflammation (161) 161
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4365) 4365
Chinese (16) 16
Japanese (13) 13
French (11) 11
Korean (7) 7
German (4) 4
Polish (2) 2
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Molecular Sciences, ISSN 1661-6596, 07/2017, Volume 18, Issue 7, p. 1414
Carcinogenesis cannot be explained only by genetic alterations, but also involves epigenetic processes. Modification of histones by acetylation plays a key... 
Histone deacetylase inhibitors | Anti-angiogenic effect | Cell cycle arrest | Drug combinations | Histone deacetylases | Autophagy | Apoptosis | Cancer | HDAC INHIBITORS | autophagy | SUBEROYLANILIDE HYDROXAMIC ACID | HUMAN LEUKEMIA-CELLS | NITRIC-OXIDE SYNTHASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR-SUPPRESSOR GENES | apoptosis | VALPROIC ACID | cell cycle arrest | anti-angiogenic effect | CHEMISTRY, MULTIDISCIPLINARY | drug combinations | CELL LUNG-CANCER | EPITHELIAL-MESENCHYMAL TRANSITION | PHASE-II TRIAL | LONG NONCODING RNA | histone deacetylases | cancer | histone deacetylase inhibitors | Immunomodulation - drug effects | Apoptosis - drug effects | Humans | Angiogenesis Inhibitors - pharmacology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Autophagy - drug effects | Acetylation - drug effects | Animals | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Cycle Checkpoints - drug effects | Angiogenesis Inhibitors - therapeutic use | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Epigenesis, Genetic - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Gene Expression Regulation, Neoplastic - drug effects | Drug Evaluation, Preclinical
Journal Article